Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
Clinical trial NCT02129556 · COMPLETED
Trial details
- NCT number
- NCT02129556
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-08-04
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.